Moberg Pharma AB (publ) (STO: MOB)

Moberg Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,499	1,710	2,269	2,296	1,134	-
Market Cap Growth	-31.61%	-24.65%	-1.15%	102.44%	-	-
Enterprise Value	1,177	1,730	2,302	2,346	1,290	-
Last Close Price	32.10	21.33	28.31	28.64	20.58	-
PE Ratio	-	46.38	19.26	110.16	55.13	-
PS Ratio	165.80	10.28	15.65	16.18	6.98	-
PB Ratio	1.58	1.31	1.58	1.74	1.49	-
P/FCF Ratio	-20.76	-15.65	-7.41	-5.14	-5.25	-
P/OCF Ratio	72.51	109.36	-8.56	-111.38	-13.90	-
EV/Sales Ratio	238.77	10.40	15.87	16.54	7.94	-
EV/EBITDA Ratio	25.00	31.48	16.71	61.88	35.94	-
EV/EBIT Ratio	35.32	44.42	19.03	91.94	45.99	-
EV/FCF Ratio	-19.15	-15.83	-7.52	-5.25	-5.97	-
Debt / Equity Ratio	0.26	0.27	0.07	0.14	0.30	0.60
Debt / EBITDA Ratio	6.06	6.50	0.75	4.98	6.28	8.80
Debt / FCF Ratio	-4.65	-3.27	-0.34	-0.42	-1.04	-1.46
Asset Turnover	0.10	0.10	0.09	0.11	0.18	0.20
Inventory Turnover	0.61	0.69	0.53	5.55	26.58	49.08
Quick Ratio	4.29	3.40	4.22	3.29	0.88	0.45
Current Ratio	6.19	4.63	8.78	3.97	1.09	0.47
Return on Equity (ROE)	2.82%	2.70%	8.49%	1.87%	2.94%	3.35%
Return on Assets (ROA)	1.49%	1.43%	4.76%	1.23%	2.00%	1.93%
Return on Capital (ROIC)	1.54%	1.52%	4.97%	1.28%	2.22%	2.27%
Earnings Yield	-2.78%	2.16%	5.14%	0.84%	1.46%	-
FCF Yield	-4.82%	-6.39%	-13.49%	-19.47%	-19.06%	-
Dividend Yield	1.20%	1.08%	-	-	-	-
Payout Ratio	472.03%	447.43%	-	-	-	47.60%
Buyback Yield / Dilution	-	-6.23%	-67.49%	-52.65%	-7.20%
Total Shareholder Return	1.20%	1.08%	-6.23%	-67.49%	-52.65%	-7.20%

Source: S&P Capital IQ. Standard template. Financial Sources.